Alzeim.net
Title
Alzheimer's Research - Galanthamine from daffodils - Alzeim Ltd
Description
Excerpted from the website:
- ) has decided to withdraw all anti-cholinesterase treatments from the National Health Service as regards new patients, because of the high total cost of branded medicines still subject to restrictive product licence. That decision has caused an outcry from sufferers and their families, and is being disputed in the High Court. It may not be resolved until after the drugs are able to be produced and sold in generic form.
Languages
English
Additional Information
Related Domains
External Links
- Alexa: Alzeim.net
- WHOIS for Alzeim.net
